Ionis Pharmaceuticals (IONS) Other Gross PP&E Adjustments (2016 - 2025)
Ionis Pharmaceuticals (IONS) has 16 years of Other Gross PP&E Adjustments data on record, last reported at -$242.0 million in Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments fell 47.18% year-over-year to -$242.0 million; the TTM value through Sep 2025 reached -$242.0 million, down 47.18%, while the annual FY2024 figure was -$203.3 million, 15.13% up from the prior year.
- Other Gross PP&E Adjustments reached -$242.0 million in Q3 2025 per IONS's latest filing, down from -$163.9 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $39.5 million in Q4 2021 and bottomed at -$242.0 million in Q3 2025.
- Average Other Gross PP&E Adjustments over 5 years is -$168.7 million, with a median of -$174.3 million recorded in 2023.
- Peak YoY movement for Other Gross PP&E Adjustments: skyrocketed 162.84% in 2021, then tumbled 592.07% in 2022.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $39.5 million in 2021, then crashed by 592.07% to -$194.2 million in 2022, then dropped by 23.35% to -$239.5 million in 2023, then increased by 15.13% to -$203.3 million in 2024, then fell by 19.04% to -$242.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$242.0 million in Q3 2025, -$163.9 million in Q2 2025, and -$159.3 million in Q1 2025.